Analysis of 108 AML patient samples via qPCR showed that GLUT1 was increased in bone marrow mononuclear cells of AML patients without remission compared to healthy individuals and patients with complete or partial remission (50). The gene discussed is SLC2A1; the disease is acute myeloid leukemia.